INFLAMMATORY PSEUDOTUMOUR

INFLAMMATORY PSEUDOTUMOUR was reported 74 times

INFLAMMATORY PSEUDOTUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
1 Potassium Binder [EPC] 3 0.0002
2 Antimetabolite Immunosuppressant [EPC] 3 0.0001
3 Topoisomerase Inhibitor [EPC] 7 0.0001
4 Bile Acid [EPC] 2 0.0001
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 6 0.0001
6 Purine Antimetabolite [EPC] 5 0.0001
7 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
8 Alkylating Drug [EPC] 8 0.0000
9 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
10 Fluoroquinolone Antibacterial [EPC] 3 0.0000
11 Vascular Endothelial Growth Factor Inhibitor [EPC] 4 0.0000
12 Copper-containing Intrauterine Device [EPC] 1 0.0000
13 Antirheumatic Agent [EPC] 2 0.0000
14 Platinum-based Drug [EPC] 5 0.0000
15 Corticosteroid [EPC] 23 0.0000
16 Folate Analog Metabolic Inhibitor [EPC] 7 0.0000
17 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
18 Microtubule Inhibitor [EPC] 2 0.0000
19 Integrin Receptor Antagonist [EPC] 1 0.0000
20 Interferon beta [EPC] 2 0.0000
21 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
22 Aminosalicylate [EPC] 1 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
24 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
25 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
26 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
28 Janus Kinase Inhibitor [EPC] 1 0.0000
29 Anti-epileptic Agent [EPC] 1 0.0000
30 Benzodiazepine [EPC] 3 0.0000
31 Vitamin D [EPC] 1 0.0000
32 Vitamin B12 [EPC] 1 0.0000
33 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
34 Vitamin C [EPC] 1 0.0000
35 Insulin Analog [EPC] 1 0.0000
36 Loop Diuretic [EPC] 1 0.0000
37 Kinase Inhibitor [EPC] 1 0.0000
38 Platelet Aggregation Inhibitor [EPC] 1 0.0000
39 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000